Cell and gene therapies are moving from clinical trials to mainstream formularies — and health systems are racing to keep pace. This panel examines the governance frameworks, storage and handling workflows, financial models and multidisciplinary care coordination required to administer these complex therapies safely. Leaders share how they built the operational infrastructure needed to become qualified treatment centers.